Regencell Bioscience Holdings Limited (RGC)

Profile

https://www.regencellbioscience.com

Regencell Bioscience Holdings Limited is an early-stage bioscience company focused on the research, development, and commercialization of traditional Chinese medicine-based products. Regencell Bioscience Holdings Limited concentrates on treatments for neurocognitive disorders and degeneration, with particular attention to attention deficit hyperactivity disorder and autism spectrum disorder. The company also applies its bioscience platform to infectious diseases that affect the immune system, reflecting a broader therapeutic scope within natural and holistic healthcare. Its product development approach centers on standardized TCM formulations designed for clinical use, positioning the company within the specialty biopharmaceutical segment of the health technology market. Regencell Bioscience Holdings Limited serves as a niche participant in the medical and pharmaceutical landscape by targeting conditions with unmet treatment needs through non-conventional medicine-based research and commercialization.